Carrie Croy

Carrie Croy is the Director of Biology at Eli Lilly and Company, where they previously served as a Senior Research Scientist. Their research encompasses the fields of neuroscience, molecular pharmacology, and protein chemistry, with a focus on characterizing PAM ligands for treating schizophrenia. Carrie held roles as a Postdoctoral Scientist in neuroscience and Research Scientist at Molecular Kinetics, contributing to innovative polypeptide development and leading Phase II NIH SBIR Grants. They completed a Ph.D. in Chemistry at the University of California, San Diego, following a B.S. in Chemistry from Loyola University of Chicago.